Patent Law Weblog
recent posts
- Quo Vadis mRNA Vaccine Technology? The State of the IP Lawsuits
- Moderna Settles Patent Litigation with Arbutus et al.
- USPTO and DOJ Statement of Interest in Collision Communications: Another Thumb on the Scale in Favor of NPE Patent Plaintiffs
- Oasis Tooling, Inc. v. Siemens Industry Software Inc. (Fed. Cir. 2026)
- Why AI Will Not Take Over the World
about
Category: International IP
-
By Donald Zuhn — On Friday, the World Intellectual Property Organization (WIPO) announced that the member states of WIPO's Patent Cooperation Treaty (PCT) had endorsed a series of recommendations for enhancing the international patent system. The announcement came at the conclusion of PCT Working Group discussions that took place from June 14-18, 2010. WIPO…
-
By Damian Slizys — Following the discussion in Patent Docs of the Australian Senate's gene patent inquiry last December (see "Gene Patenting: Australian Potpourri"), we now expect the findings of the Senate enquiry to be set down on 17 June 2010, following two extensions of time. The inquiry was allegedly initiated, in part, because…
-
By Kevin E. Noonan — At the end of last month, the U.S. Trade Representative, Ron Kirk, issued the 2010 Special 301 Report, which according to the USTR website "reflects the Administration's resolve to encourage and maintain effective [Intellectual Property Rights (IPR)] protection and enforcement worldwide" by identifying "a wide range of serious concerns,…
-
By Christopher P. Singer — The U.S. Patent and Trademark Office sent out an e-mail alert on March 26, 2010 advising that it has been informed by the International Bureau of the World Intellectual Property Organization (WIPO) that the European Patent Office (EPO) will decrease its search fee when acting as the International Search…
-
By Sarah Fendrick — The U.S. Patent and Trademark Office (USPTO) announced in a March 10, 2010 press release that it has joined forces with the UK Intellectual Property Office (UKIPO) to develop a plan to reduce patent processing backlogs in both offices. The joint effort is a result of the hindrance the patent…
-
By Juan Serrano — Back in 2003, Mexico enacted linkage regulations to avoid the granting of marketing authorizations in violation of patent rights. The system created by these regulations is far less elaborate than the one set forth by the Hatch-Waxman act in the U.S., as there is no extension/term restoration, and there is…
-
By Bradley Crawford — On February 19, 2010, the European Patent Office Enlarged Board of Appeals issued its decision in In re Abbott Respiratory, G 0002/08 (EPO Enlarged Board of Appeal 2010). In this decision, three questions were considered by the Enlarged Board, but only the third question will be considered here: (3) Are any…
-
By James DeGiulio — On December 4, 2009, the European Competitiveness Council unanimously adopted a legislative package designed to create a single EU patent and EU patent court. In a press release issued by the Council of the EU, the Council concluded that enhancing the patent system in Europe is a necessary prerequisite for…
-
By Donald Zuhn — In January, GlaxoSmithKline announced a series of initiatives for developing new medicines to combat diseases that disproportionately affect the world's poorest countries. The initiatives, which comprise GSK's "open innovation" strategy, were outlined in a speech given by GSK Chief Executive Andrew Witty to the Council on Foreign Relations on January…
-
By Kevin E. Noonan — Gene patenting, and proposed bans on the practice, have garnered several newspaper reports and responses from professional groups around the world. Australian Senate Panel Debates Gene Patenting The Community Affairs Committee of the Australian Senate is investigating whether genes should be patentable in that country, according to a December…
Patent Docs 